ArticleTransboundary and emerging diseases2026
Seroprevalence of Epizootic Hemorrhagic Disease Virus in Cattle, Sheep, and Goats in New York State From 2022 Through 2025.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seroprevalence of Epizootic Hemorrhagic Disease Virus in Cattle, Sheep, and Goats in New York State From 2022 Through 2025.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Epizootic hemorrhagic disease (EHD) virus (EHDV) is a vector-borne virus transmitted by Culicoides midges that infects domestic and wild ruminants. EHDV causes high mortality in white-tailed deer (WTD) and oral lesions mimicking foot and mouth disease (FMD) in cattle. Small ruminants (e.g., domestic sheep, domestic goats) seroconvert but do not typically develop disease. In 2021, ~2100 WTD deaths were attributed to EHD in New York (NY) State. That same year, an EHD outbreak at a NY dairy resulted in a foreign animal disease (FAD) investigation to rule out FMD, and EHDV was detected in a captive bison herd in NY. In response to the EHD outbreak affecting wildlife, agricultural, and exhibition animals, serum samples from cattle, sheep, and goats submitted to the Cornell University College of Veterinary Medicine Animal Health Diagnostic Center (AHDC) were tested for EHDV antibodies. The samples tested in our surveillance study included samples collected during and after Culicoides vector activity (July-January) over three seasons from 2022 to 2025. A total of 5698 samples comprising 4874 cattle and 824 small ruminants were tested using the agar gel immunodiffusion assay (AGID). Season 1 had 0.6% seroprevalence (10/1719), season 2 had 0.7% seroprevalence (15/2021), season 3 had 0.5% seroprevalence (9/1958) with an overall seroprevalence of 0.6%. Neutralizing antibody (NA) titers were determined on all AGID positive samples for EHDV serotypes 1, 2, and 6. There were 20 samples positive for EHDV serotype 2 (NA titers from 1:40 to ≥ 1:1280); 11 samples positive for EHDV serotype 6 (NA titers from 1:10 to 1:640); and three animals with cross-reaction amongst serotypes. Of the 34 positive samples, 31 were from cattle and 3 were from sheep. Nineteen samples were from counties with large numbers of WTD deaths attributed to EHDV in 2021 or counties with cases of EHDV in cattle. This data indicates that EHDV serotypes 2 and 6 subclinically infected a small number of domestic ruminants in NY from 2022 to 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.